Chronic hand eczema (CHE) is one of the most persistent inflammatory skin conditions in adults. About one-third of patients suffer from moderate to severe hand eczema. The treatment of CHE aims to provide long-term relief of symptoms so that patients can achieve a good quality of life and resume their normal daily activities. Many of those affected either do not respond adequately to topical steroids (TCS) or experience side effects with prolonged use. Therefore, for long-term management, it is advisable to use a well-tolerated, effective steroid-free option.
You May Also Like
- Across All Types of Cancer
Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
- Obesity: More than half of those affected have fatty liver disease
From screening to multimodal intervention with GLP-1-RA or resmetirom
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib
First-class immunomodulation combined with convenience—the data available so far is convincing
- Preclinical Study on a Special Ginkgo biloba Extract
What role do proanthocyanidins play?
- Myasthenia gravis: immunomodulatory therapies for long-term treatment
Expanded Possibilities Thanks to Innovative Classes of Active Ingredients
- Interstitial Lung Diseases
Update on Idiopathic Pulmonary Fibrosis
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Ischemic stroke: Are smaller or larger brain arteries affected?